Lumea integrates Nonagen’s Oncuria® urine-based bladder cancer tests (Detect, Monitor, Predict) into its platform, ...

Anktiva is now approved for BCG-unresponsive papillary-only bladder cancer. Here’s what the bladder-sparing option involves, from timeline to risks. For people with non-muscle invasive bladder cancer ...

Bladder cancer detection could get easier, faster and much less invasive as a new urine test can help identify it. According to new UK research, patients may not have to wait for an invasive bladder ...

Bladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating continuous monitoring. Late detection often requires major surgeries, such as ...

There are several urodynamic tests a doctor may recommend. You may need multiple tests for a full diagnosis. Urodynamic tests see how well your urinary tract, especially your bladder, urethra, and ...

MIT researchers created a nanosensor catheter that detects bladder cancer biomarkers far earlier than current tests.

Bladder cancer has a cure rate of over 90% when detected early, but it has a high recurrence rate of 70%, necessitating continuous monitoring. Late detection often requires major surgeries such as ...

"Let's perform a urine cytology test" Have you ever been told this when visiting a urologist? You have likely experienced a ...

Stage 2 bladder cancer is an advanced bladder cancer stage. It is a muscle-invasive form of bladder cancer, which means the tumor has spread into the muscle layer of the bladder lining. Bladder cancer ...